Literature DB >> 2205513

Retinoic acid induced differentiated neuroblastoma cells show increased expression of the beta A4 amyloid gene of Alzheimer's disease and an altered splicing pattern.

G König1, C L Masters, K Beyreuther.   

Abstract

Retinoic acid (RA) induced differentiation of SH-SY5Y neuroblastoma cells is associated with more than a tenfold induction of total Alzheimer's disease beta A4 amyloid protein precursor (APP) mRNA as analyzed by Northern blot hybridisation. S1 nuclease protection experiments reveal that the splicing pattern of these differentiated cells is altered in favor of APP695 mRNA, coding for the shortest amyloidogenic beta A4 amyloid precursor protein. Induction of differentiation of SH-SY5Y cells with NGF leads to a fivefold increase of total APP mRNA without change in the splicing pattern. This suggests that RA but not NGF induces factor(s) which are responsible for an APP hnRNA splicing favoring APP695 mRNA.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2205513     DOI: 10.1016/0014-5793(90)81181-m

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  18 in total

1.  The gamma -secretase-cleaved C-terminal fragment of amyloid precursor protein mediates signaling to the nucleus.

Authors:  Y Gao; S W Pimplikar
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-11       Impact factor: 11.205

2.  The expression of the amyloid precursor protein (APP) is regulated by two GC-elements in the promoter.

Authors:  P Pollwein; C L Masters; K Beyreuther
Journal:  Nucleic Acids Res       Date:  1992-01-11       Impact factor: 16.971

Review 3.  The role of glycoproteins in neural development function, and disease.

Authors:  K C Breen; C M Coughlan; F D Hayes
Journal:  Mol Neurobiol       Date:  1998-04       Impact factor: 5.590

4.  The Na+/H+ exchanger NHE6 modulates endosomal pH to control processing of amyloid precursor protein in a cell culture model of Alzheimer disease.

Authors:  Hari Prasad; Rajini Rao
Journal:  J Biol Chem       Date:  2015-01-05       Impact factor: 5.157

Review 5.  Proteoglycans and the acute-phase response in Alzheimer's disease brain.

Authors:  B Leveugle; H Fillit
Journal:  Mol Neurobiol       Date:  1994 Aug-Dec       Impact factor: 5.590

Review 6.  The role of beta-amyloid peptide in Alzheimer's disease.

Authors:  A LeBlanc
Journal:  Metab Brain Dis       Date:  1994-03       Impact factor: 3.584

7.  Disabled-1 binds to the cytoplasmic domain of amyloid precursor-like protein 1.

Authors:  R Homayouni; D S Rice; M Sheldon; T Curran
Journal:  J Neurosci       Date:  1999-09-01       Impact factor: 6.167

8.  Molecular pathology of the X-linked hyper-immunoglobulin M syndrome: detection of wild-type transcripts in a patient with a complex splicing defect of the CD40 ligand.

Authors:  R Ameratunga; J McKee; J French; R Prestidge; W Fanslow; J Marbrook
Journal:  Clin Diagn Lab Immunol       Date:  1996-11

9.  DNA binding and regulatory effects of transcription factors SP1 and USF at the rat amyloid precursor protein gene promoter.

Authors:  P W Hoffman; J M Chernak
Journal:  Nucleic Acids Res       Date:  1995-06-25       Impact factor: 16.971

Review 10.  Disturbances in signal transduction mechanisms in Alzheimer's disease.

Authors:  C J Fowler; R F Cowburn; A Garlind; B Winblad; C O'Neill
Journal:  Mol Cell Biochem       Date:  1995 Aug-Sep       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.